Viewing nowAtorvastatin Tablets 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
RP Bio Co., Ltd.

MFDS item code 201601146 · Approved 2016.02.29 · Insurance code 661604640
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular diseases (e.g., myocardial infarction)
This medication helps reduce the risk of cardiovascular diseases. It lowers the risk of myocardial infarction and stroke in patients with various risk factors such as older age, smoking, hypertension, low HDL cholesterol, and diabetes. It is also effective in preventing heart-related problems such as angina or requiring vascular surgery. In patients with hyperlipidemia, this drug reduces total cholesterol, LDL cholesterol, and triglyceride levels, while increasing HDL cholesterol, thereby improving blood lipid levels. It can especially be used as an adjunctive treatment for patients with familial hypercholesterolemia or when dietary control alone is insufficient. This drug is also effective as an adjunctive treatment in pediatric patients with severe hypercholesterolemia. In summary, this medication is used to reduce the risk of cardiovascular diseases and to improve cardiovascular health by regulating blood lipids.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. It may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily. Patients requiring greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of more than 45 % is required). This medicine is administered in a dosage range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and adjust the dose accordingly. Because the goal of treatment is to reduce LDL cholesterol, use of LDL cholesterol levels is recommended when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels may be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia: The dosage is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when these treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on administration of doses higher than 20 mg of this medicine in pediatric patients).
This medication may cause muscle symptoms; therefore, it should be discontinued immediately if there is severe muscle pain or weakness, or if Creatine Kinase levels increase significantly. This medication should not be taken by individuals with certain diseases or allergies, by pregnant women or women who may become pregnant, or by children under 10 years of age. Those with liver or kidney problems or risk factors for myopathy such as alcoholism or hypothyroidism should exercise caution while taking this drug. Various side effects such as liver function abnormalities, skin rash, headache, dyspepsia, and muscle pain may occur while taking this medication; if symptoms arise, consult your doctor. Since this drug is metabolized in the liver, care should be taken when taken with certain antibiotics, antifungals, or antiviral medications, as this may increase blood concentration and the risk of side effects. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should use appropriate contraception during treatment. Elderly patients or those with impaired kidney function have a higher risk of myopathy, so muscle condition should be closely monitored during treatment. In cases of overdose, there is no specific antidote, and treatment should be symptomatic; regular monitoring of liver function tests and muscle enzyme levels is necessary. This medication should be stored out of the reach of children and kept in its original container, as transferring to another container may risk degradation of quality or misuse.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is important to maintain the storage temperature between 1 and 30 degrees Celsius. This will ensure the effectiveness is well maintained and safe to use.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
RP Bio Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.